{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:21:40Z","timestamp":1790734900879,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajpc.2025.101008","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T23:34:48Z","timestamp":1747956888000},"page":"101008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The interactions of Lipoprotein(a) with common cardiovascular risk factors in cardiovascular disease risk: evidence based on the UK Biobank"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3009-3274","authenticated-orcid":false,"given":"Linjun","family":"Ao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Noordam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Wouter","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"van Heemst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Willems van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajpc.2025.101008_bib0001","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1699-0463.1963.tb01808.x","article-title":"A NEW SERUM TYPE SYSTEM IN MAN\u2014THE lp SYSTEM","volume":"59","author":"K\u00e5re","year":"1963","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101008_bib0002","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamacardio.2022.0987","article-title":"Lipoprotein(a) and its significance in cardiovascular disease: A review","volume":"7","author":"Duarte Lau","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101008_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.100940","article-title":"Lipoprotein(a) levels in disaggregated racial and ethnic subgroups across atherosclerotic cardiovascular disease risk levels","volume":"3","author":"Dudum","year":"2024","journal-title":"JACC Adv"},{"issue":"24","key":"10.1016\/j.ajpc.2025.101008_bib0004","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood Cholesterol: Executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101008_bib0005","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.cjca.2021.03.016","article-title":"2021 Canadian Cardiovascular Society Guidelines for the management of dyslipidemia for the prevention of Cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ajpc.2025.101008_bib0006","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.ajpc.2025.101008_bib0007","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"issue":"26","key":"10.1016\/j.ajpc.2025.101008_bib0008","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ajpc.2025.101008_bib0009","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Nordestgaard B\u00f8rge G. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup Pia","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101008_bib0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jacc.2019.03.524","article-title":"Elevated lipoprotein(a) and risk of ischemic stroke","volume":"74","author":"Langsted","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.101008_bib0011","doi-asserted-by":"crossref","unstructured":"Kumar P., Swarnkar P., Misra S., Nath M. Lipoprotein(a) level as a risk factor for stroke and its subtype: A systematic review and meta-analysis. Sci Rep. 2021;11(1):15660.","DOI":"10.1038\/s41598-021-95141-0"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101008_bib0012","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101008_bib0013","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101008_bib0014","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCGENETICS.113.000400","article-title":"Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective mendelian randomization study and replication in a case-control cohort","volume":"7","author":"Arsenault","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101008_bib0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/jamacardio.2017.4266","article-title":"Association of LPA variants with aortic stenosis: A large-scale study using diagnostic and procedural codes from electronic health records","volume":"3","author":"Chen","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101008_bib0016","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/cvr\/cvad062","article-title":"Lipoprotein(a) and calcific aortic valve disease initiation and progression: a systematic review and meta-analysis","volume":"119","author":"Pantelidis","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101008_bib0017","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11883-023-01113-2","article-title":"Lipoprotein apheresis: current recommendations for treating familial hypercholesterolemia and elevated Lipoprotein(a)","volume":"25","author":"Safarova","year":"2023","journal-title":"Curr Atheroscler Rep"},{"issue":"10057","key":"10.1016\/j.ajpc.2025.101008_bib0018","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(16)31009-1","article-title":"Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials","volume":"388","author":"Viney","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101008_bib0019","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101008_bib0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12872-022-02618-5","article-title":"The correlation between lipoprotein(a) elevations and the risk of recurrent cardiovascular events in CAD patients with different LDL-C levels","volume":"22","author":"Zhu","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ajpc.2025.101008_bib0021","article-title":"Baseline low-density-lipoprotein cholesterol modifies the risk of all-cause death associated with elevated lipoprotein(a) in coronary artery disease patients","volume":"8","author":"Yao","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"13","key":"10.1016\/j.ajpc.2025.101008_bib0022","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwad059","article-title":"Interaction between elevated lipoprotein(a) and LDL cholesterol on mortality risk in patients with coronary artery disease","volume":"30","author":"Dykun","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2025.101008_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2019.10.044","article-title":"Interaction of lipoprotein(a) with low-density lipoprotein cholesterol on first incident acute myocardial infarction","volume":"501","author":"Hu","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"27","key":"10.1016\/j.ajpc.2025.101008_bib0024","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1093\/eurheartj\/ehy334","article-title":"Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting","volume":"39","author":"Verbeek","year":"2018","journal-title":"Eur Heart J"},{"issue":"10226","key":"10.1016\/j.ajpc.2025.101008_bib0025","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"395","author":"Yusuf","year":"2020","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ajpc.2025.101008_bib0026","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101008_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"issue":"7726","key":"10.1016\/j.ajpc.2025.101008_bib0028","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101008_bib0029","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.113.004406","article-title":"Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin)","volume":"129","author":"Khera","year":"2014","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ajpc.2025.101008_bib0030","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/sim.2165","article-title":"Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure","volume":"24","author":"Tobin","year":"2005","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101008_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.HYP.0000022660.28915.B1","article-title":"Genome scans for blood pressure and hypertension: the National Heart, Lung, and Blood Institute Family Heart Study","volume":"40","author":"Hunt","year":"2002","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101008_bib0032","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.amjhyper.2005.01.011","article-title":"A summary of the effects of antihypertensive medications on measured blood pressure","volume":"18","author":"Wu","year":"2005","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101008_bib0033","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.HYP.0000044938.94050.E3","article-title":"Antihypertensive treatments obscure familial contributions to blood pressure variation","volume":"41","author":"Cui","year":"2003","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101008_bib0034","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ajhg.2014.05.010","article-title":"Gene-age interactions in blood pressure regulation: a large-scale investigation with the CHARGE, Global BPgen, and ICBP Consortia","volume":"95","author":"Simino","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101008_bib0035","volume":"3","author":"VanderWeele Tyler","year":"2014","journal-title":"Tutor Interact Epidemiol Methods"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101008_bib0036","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1097\/EDE.0000000000000752","article-title":"Function for additive interaction measures","volume":"29","author":"Mathur","year":"2018","journal-title":"Epidemiology"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101008_bib0037","first-page":"1866","article-title":"Triangulation in aetiological epidemiology","volume":"45","author":"Lawlor","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101008_bib0038","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jamacardio.2018.1470","article-title":"Association of LPA variants with risk of coronary disease and the implications for lipoprotein(a)-lowering therapies: A mendelian randomization analysis","volume":"3","author":"Burgess","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101008_bib0039","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101008_bib0040","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","article-title":"Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes","volume":"50","author":"Malik","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpc.2025.101008_bib0041","unstructured":"Kurki Mitja I., Karjalainen Juha, Palta Priit, Sipil\u00e4 Timo P., Kristiansson Kati, Donner Kati, et al. FinnGen: unique genetic insights from combining isolated population and national health register data. medRxiv. 2022:2022.03.03.22271360."},{"issue":"7","key":"10.1016\/j.ajpc.2025.101008_bib0042","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10654-022-00879-0","article-title":"Avoiding collider bias in mendelian randomization when performing stratified analyses","volume":"37","author":"Coscia","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ajpc.2025.101008_bib0043","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11122","article-title":"Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA","volume":"7","author":"Kettunen","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101008_bib0044","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12944-023-01860-w","article-title":"Association of apolipoproteins and lipoprotein(a) with metabolic syndrome: a systematic review and meta-analysis","volume":"22","author":"Ulloque-Badaracco","year":"2023","journal-title":"Lipids Health Dis"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101008_bib0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/MOL.0000000000000171","article-title":"LDL-C' = LDL-C + lp(a)-C: implications of achieved ultra-low LDL-C levels in the proprotein convertase subtilisin\/kexin type 9 era of potent LDL-C lowering","volume":"26","author":"Yeang","year":"2015","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ajpc.2025.101008_bib0046","series-title":"Quantification of LDL-Cholesterol Corrected for Molar Concentration of Lipoprotein(a)","author":"Rosenson","year":"2022"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101008_bib0047","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/ATVBAHA.120.315291","article-title":"Lp(a) (lipoprotein[a] concentrations and incident atherosclerotic cardiovascular disease: new insights from a large national biobank","volume":"41","author":"Patel","year":"2021","journal-title":"Arter Thromb Vasc Biol"},{"key":"10.1016\/j.ajpc.2025.101008_bib0048","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.amjcard.2021.12.014","article-title":"Impact of lipoprotein(a) as a residual risk factor in long-term cardiovascular outcomes in patients with acute coronary syndrome treated with statins","volume":"168","author":"Takahashi","year":"2022","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101008_bib0049","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/phar.2851","article-title":"Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies","volume":"43","author":"Alhomoud","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ajpc.2025.101008_bib0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.atherosclerosis.2022.09.007","article-title":"Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): effects on coronary artery disease and ischemic stroke","volume":"361","author":"De Marchis","year":"2022","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101008_bib0051","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jacc.2021.04.102","article-title":"Lipoprotein(a) and benefit of PCSK9 inhibition in patients with nominally controlled LDL cholesterol","volume":"78","author":"Schwartz","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101008_bib0052","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12872-020-01626-7","article-title":"Interaction between lipoprotein(a) levels and body mass index in first incident acute myocardial infarction","volume":"20","author":"Teng","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101008_bib0053","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jacc.2021.11.043","article-title":"Lipoprotein(a) and body mass compound the risk of calcific aortic valve disease","volume":"79","author":"Kaltoft","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101008_bib0054","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/HYPERTENSIONAHA.122.20189","article-title":"Association of Lp(a) (Lipoprotein[a] and Hypertension in primary prevention of cardiovascular disease: the MESA","volume":"80","author":"Rikhi","year":"2023","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101008_bib0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCIMAGING.112.980052","article-title":"Sex differences in aortic valve calcification measured by multidetector computed tomography in aortic stenosis","volume":"6","author":"Aggarwal","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101008_bib0056","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/CIRCRESAHA.116.309306","article-title":"Sex-related discordance between aortic valve calcification and hemodynamic severity of aortic stenosis: is valvular fibrosis the explanation?","volume":"120","author":"Simard","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2025.101008_bib0057","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3389\/fphar.2020.00685","article-title":"Calcific aortic valve disease-natural history and future therapeutic strategies","volume":"11","author":"Alushi","year":"2020","journal-title":"Front Pharmacol"},{"issue":"24","key":"10.1016\/j.ajpc.2025.101008_bib0058","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/eurheartj\/ehaa172","article-title":"Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: mendelian randomization in the Copenhagen General Population Study","volume":"41","author":"Kaltoft","year":"2020","journal-title":"Eur Heart J"},{"issue":"40","key":"10.1016\/j.ajpc.2025.101008_bib0059","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1093\/eurheartj\/ehaa070","article-title":"Plasma lipids and risk of aortic valve stenosis: a mendelian randomization study","volume":"41","author":"Nazarzadeh","year":"2020","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.ajpc.2025.101008_bib0060","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/eurheartj\/ehab081","article-title":"Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study","volume":"42","author":"Arnold","year":"2021","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101008_bib0061","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033654","article-title":"Genetics and pathophysiological mechanisms of lipoprotein(a)-associated cardiovascular risk","volume":"13","author":"Volgman","year":"2024","journal-title":"J Am Heart Assoc"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725000832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725000832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T21:20:17Z","timestamp":1749849617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667725000832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":61,"alternative-id":["S2666667725000832"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101008","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The interactions of Lipoprotein(a) with common cardiovascular risk factors in cardiovascular disease risk: evidence based on the UK Biobank","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101008"}}